Text message content preferences to improve buprenorphine maintenance treatment in primary care

Babak Tofighi, Ellie Grossman, Sewit Bereket, Joshua Lee

Research output: Contribution to journalArticle

Abstract

Few studies have evaluated text message content preferences to support evidence-based treatment approaches for opioid use disorders, and none in primary care office-based buprenorphine treatment settings. This study assessed the acceptability and preferences for a tailored text message intervention in support of core office-based buprenorphine treatment medical management components (e.g., treatment adherence, encouraging abstinence, 12-step group participation, motivational interviewing, and patient-provider communication as needed). There were 97 patients enrolled in a safety net office-based buprenorphine treatment program who completed a 24-item survey instrument that consisted of multiple-choice responses, 7-point Likert-type scales, binomial "Yes/No" questions, and open-ended responses. The sample was predominately male (81%), had an average age of 46 years, and was diverse (64% ethnic/racial minorities); 56% lacked stable employment. Respondents were interested in receiving text message appointment reminders (90%), information pertaining to their buprenorphine treatment (76%), supportive content (70%), and messages to reduce the risk of relapse (88%). Participants preferred to receive relapse prevention text messages during all phases of treatment: immediately after induction into buprenorphine treatment (81%), a "few months" into treatment (57%), and after discontinuing buprenorphine treatment (72%). Respondents also expressed interest in text message content enhancing self-efficacy, social support, and frequent provider communication to facilitate unobserved "home" induction with buprenorphine. Older participants were significantly less receptive to receiving text message appointment reminders; however, they were as interested in receiving supportive, informational, and relapse prevention components compared to younger respondents. Implications for integrating a text message support system in office-based buprenorphine treatment are discussed.

Original languageEnglish (US)
Pages (from-to)92-100
Number of pages9
JournalJournal of Addictive Diseases
Volume35
Issue number2
DOIs
StatePublished - Apr 2 2016

Fingerprint

Text Messaging
Buprenorphine
Primary Health Care
Therapeutics
Secondary Prevention
Appointments and Schedules
Communication
Motivational Interviewing
Self Efficacy
Social Support
Opioid Analgesics

Keywords

  • Buprenorphine
  • mHealth
  • opioid dependence
  • text messaging

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Text message content preferences to improve buprenorphine maintenance treatment in primary care. / Tofighi, Babak; Grossman, Ellie; Bereket, Sewit; Lee, Joshua.

In: Journal of Addictive Diseases, Vol. 35, No. 2, 02.04.2016, p. 92-100.

Research output: Contribution to journalArticle

Tofighi, Babak ; Grossman, Ellie ; Bereket, Sewit ; Lee, Joshua. / Text message content preferences to improve buprenorphine maintenance treatment in primary care. In: Journal of Addictive Diseases. 2016 ; Vol. 35, No. 2. pp. 92-100.
@article{f4820296650a4d729298195dceff4675,
title = "Text message content preferences to improve buprenorphine maintenance treatment in primary care",
abstract = "Few studies have evaluated text message content preferences to support evidence-based treatment approaches for opioid use disorders, and none in primary care office-based buprenorphine treatment settings. This study assessed the acceptability and preferences for a tailored text message intervention in support of core office-based buprenorphine treatment medical management components (e.g., treatment adherence, encouraging abstinence, 12-step group participation, motivational interviewing, and patient-provider communication as needed). There were 97 patients enrolled in a safety net office-based buprenorphine treatment program who completed a 24-item survey instrument that consisted of multiple-choice responses, 7-point Likert-type scales, binomial {"}Yes/No{"} questions, and open-ended responses. The sample was predominately male (81{\%}), had an average age of 46 years, and was diverse (64{\%} ethnic/racial minorities); 56{\%} lacked stable employment. Respondents were interested in receiving text message appointment reminders (90{\%}), information pertaining to their buprenorphine treatment (76{\%}), supportive content (70{\%}), and messages to reduce the risk of relapse (88{\%}). Participants preferred to receive relapse prevention text messages during all phases of treatment: immediately after induction into buprenorphine treatment (81{\%}), a {"}few months{"} into treatment (57{\%}), and after discontinuing buprenorphine treatment (72{\%}). Respondents also expressed interest in text message content enhancing self-efficacy, social support, and frequent provider communication to facilitate unobserved {"}home{"} induction with buprenorphine. Older participants were significantly less receptive to receiving text message appointment reminders; however, they were as interested in receiving supportive, informational, and relapse prevention components compared to younger respondents. Implications for integrating a text message support system in office-based buprenorphine treatment are discussed.",
keywords = "Buprenorphine, mHealth, opioid dependence, text messaging",
author = "Babak Tofighi and Ellie Grossman and Sewit Bereket and Joshua Lee",
year = "2016",
month = "4",
day = "2",
doi = "10.1080/10550887.2015.1127716",
language = "English (US)",
volume = "35",
pages = "92--100",
journal = "Journal of Addictive Diseases",
issn = "1055-0887",
publisher = "Routledge",
number = "2",

}

TY - JOUR

T1 - Text message content preferences to improve buprenorphine maintenance treatment in primary care

AU - Tofighi, Babak

AU - Grossman, Ellie

AU - Bereket, Sewit

AU - Lee, Joshua

PY - 2016/4/2

Y1 - 2016/4/2

N2 - Few studies have evaluated text message content preferences to support evidence-based treatment approaches for opioid use disorders, and none in primary care office-based buprenorphine treatment settings. This study assessed the acceptability and preferences for a tailored text message intervention in support of core office-based buprenorphine treatment medical management components (e.g., treatment adherence, encouraging abstinence, 12-step group participation, motivational interviewing, and patient-provider communication as needed). There were 97 patients enrolled in a safety net office-based buprenorphine treatment program who completed a 24-item survey instrument that consisted of multiple-choice responses, 7-point Likert-type scales, binomial "Yes/No" questions, and open-ended responses. The sample was predominately male (81%), had an average age of 46 years, and was diverse (64% ethnic/racial minorities); 56% lacked stable employment. Respondents were interested in receiving text message appointment reminders (90%), information pertaining to their buprenorphine treatment (76%), supportive content (70%), and messages to reduce the risk of relapse (88%). Participants preferred to receive relapse prevention text messages during all phases of treatment: immediately after induction into buprenorphine treatment (81%), a "few months" into treatment (57%), and after discontinuing buprenorphine treatment (72%). Respondents also expressed interest in text message content enhancing self-efficacy, social support, and frequent provider communication to facilitate unobserved "home" induction with buprenorphine. Older participants were significantly less receptive to receiving text message appointment reminders; however, they were as interested in receiving supportive, informational, and relapse prevention components compared to younger respondents. Implications for integrating a text message support system in office-based buprenorphine treatment are discussed.

AB - Few studies have evaluated text message content preferences to support evidence-based treatment approaches for opioid use disorders, and none in primary care office-based buprenorphine treatment settings. This study assessed the acceptability and preferences for a tailored text message intervention in support of core office-based buprenorphine treatment medical management components (e.g., treatment adherence, encouraging abstinence, 12-step group participation, motivational interviewing, and patient-provider communication as needed). There were 97 patients enrolled in a safety net office-based buprenorphine treatment program who completed a 24-item survey instrument that consisted of multiple-choice responses, 7-point Likert-type scales, binomial "Yes/No" questions, and open-ended responses. The sample was predominately male (81%), had an average age of 46 years, and was diverse (64% ethnic/racial minorities); 56% lacked stable employment. Respondents were interested in receiving text message appointment reminders (90%), information pertaining to their buprenorphine treatment (76%), supportive content (70%), and messages to reduce the risk of relapse (88%). Participants preferred to receive relapse prevention text messages during all phases of treatment: immediately after induction into buprenorphine treatment (81%), a "few months" into treatment (57%), and after discontinuing buprenorphine treatment (72%). Respondents also expressed interest in text message content enhancing self-efficacy, social support, and frequent provider communication to facilitate unobserved "home" induction with buprenorphine. Older participants were significantly less receptive to receiving text message appointment reminders; however, they were as interested in receiving supportive, informational, and relapse prevention components compared to younger respondents. Implications for integrating a text message support system in office-based buprenorphine treatment are discussed.

KW - Buprenorphine

KW - mHealth

KW - opioid dependence

KW - text messaging

UR - http://www.scopus.com/inward/record.url?scp=84958551938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958551938&partnerID=8YFLogxK

U2 - 10.1080/10550887.2015.1127716

DO - 10.1080/10550887.2015.1127716

M3 - Article

VL - 35

SP - 92

EP - 100

JO - Journal of Addictive Diseases

JF - Journal of Addictive Diseases

SN - 1055-0887

IS - 2

ER -